National and Kapodistrian University of Athens
Ημικρανία και άλλες κεφαλαλγίες σε ασθενείς με συστηματικό ερυθηματώδη λύκο: προοπτική και ελεγχόμενη μελέτη παρακολούθησης
Abstract
dc:descriptionOBJECTIVE: To clarify whether headache, and particularly migraine, belongs to thespectrum of neurologic manifestations of systemic lupus erythematosus (SLE), thearchetypal autoimmune disease. METHODS: Consecutive SLE patients werematched 1:1 for age, gender, and level of education with healthy control subjects. Arepresentative subgroup of SLE patients were also matched with patients sufferingfrom multiple sclerosis (MS), a nervous system-specific autoimmune disease. Allstudy participants were assessed for headache present in the previous year. Anxiety,depression, and quality of life were also estimated at baseline. During the followingyear, all participants were assessed every 3 months using specific headache diaries.RESULTS: Seventy-two SLE/control pairs and 48 MS patients completed 12 monthsof follow-up. Prevalence of migraine, with or without aura, was similar between SLEpatients (21%), MS patients (23%), and controls (22%), as was the prevalence offrequent tension-type headache (TTH). Duration and severity of migraine attackswere milder in SLE patients than controls. Only chronic tension-type headache wassignificantly more prevalent in SLE patients (12.5%) compared to controls (1.4%).MS patients also presented increased frequency of chronic tension-type headache(8.3%). No associations of any headache type with particular clinical manifestations,autoantibody, or disease activity, either in SLE or MS patient groups, were found.Irrespective of the presence of headache, anxiety symptoms and impaired quality oflife were more frequent among SLE than MS patients or controls. CONCLUSIONS:There is no difference in the prevalence of headache among patients with SLE and167controls. Additionally, a distinct syndrome of headache or a pathogeneticmechanism of headache have not been demonstrated in patients with SLE.Therefore, occurrence of headache in patients with SLE does not itself requirefurther evaluation. Migraine should not be considered a manifestation of systemic ororgan-specific autoimmunity. 'Lupus headache' is a term that should better beavoided, until confirmation by further studies. Headache in patients with SLE shouldbe classified according to IHS criteria and treated as a primary headache. Thepresence of any type of headache that meets the diagnostic criteria of ICHD-II forprimary headache, including chronic TTH, does not imply exaggerated diseaseactivity of SLE or impairment of the central nervous system. Regardless of diseaseseverity of SLE, patients show an increased burden of anxiety, depression and poorperception of quality of life. There is also a need for a new large-scale class I studyusing neuroimaging, particularly in the pediatric population.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vikelis, Michail
- Βικελής, Μιχαήλ
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29497